CPL @1109 (66.7%) on 12-jun-2018 [ "drug business of _" "milestone payment from _" "several public companies , including _" "educational grant by _" "agent manufactured by _" "unrestricted educational grants from _" "educational grant from _" "educational grants from _" "unrestricted educational grant from _" "research grant funding from _" "drug manufactured by _" "prescription drug manufactured by _" "_ has the worldwide rights" "placebo were provided by _" "brand name used by _" "multinational companies such as _" "unrestricted grant from _" "unconditional educational grant from _" "multinational corporations such as _" ] using aventis_pharma
relations
NELL has only weak evidence for items listed in grey